Myenteric plexitis in enteric dysmotility: What are the implications for clinical practice?

Gut

Volumn 58, Issue 8, 2009, Pages 1042-1043

  Kellow, John E ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE;

CD3+ T LYMPHOCYTE; CLINICAL PRACTICE; ENTERITIS; ENTEROPATHY; HUMAN; INTESTINAL DYSMOTILITY; IRRITABLE COLON; JEJUNUM BIOPSY; MANOMETRY; MYENTERIC GANGLIONITIS; MYENTERIC PLEXITIS; MYENTERIC PLEXUS; NEUROPATHY; NOTE; PRIORITY JOURNAL;

BIOPSY; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MYENTERIC PLEXUS; NEURITIS;

EID: 67650272782     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.175075     Document Type: Note

References (14)

1. Wingate D, Hongo M, Kellow J, et al. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002;17(Suppl):S1-14.
2. Lindberg G, Tornblom H, Iwarzon M, et al. Full thickness biopsy findings in chronic intestinal pseudoobstruction and enteric dysmotility. Gut 2009;58:1084-90.
3. Tornblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-9.
4. Spiller RC. Neuropathology of IBS? Gastroenterology 2002;123:2144-7.
5. Roberts CG, Hummers LK, Ravich WJ, et al. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 2006;55:1697-703.
6. Schwartz NT, Kalff JC, Turler A, et al. Selective jejunal manipulation causes postoperative pan-enteric inflammation and dysmotility. Gastroenterology 2004;126:159-69.
7. Di Nardo G, Blandizzi C, Volta U, et al. Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther 2008;28:25-42.
8. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004;16:515-31.
9. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-90.
10. Tornblom H, Lang B, Clover L, et al. Autoantibodies in patients with gut motility disorders and enteric neuropathy. Scand J Gastroenterol 2007;42:1289-93.
11. Camilleri M, Bharucha AE, Di Lorenzo C, et al. American Neurogastroenterology and Motility Society Consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008;20:1269-82.
12. Malagelada C, De Iono F, Azpiroz F, et al. New insight into intestinal motor function via non invasive endoluminal image analysis. Gastroenterology 2008;135:1155-62.
13. Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted fullthickness bowel biopsy. Neurogastroenterol Motil 2008;20:774-9.
14. De Giorgio R, Barbara G, Staghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction. A study of three cases. Am J Gastroenterol 2002;97:2454-9.